Bupivacaine | Market Exclusivity | US | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Bupivacaine
US Exclusivities

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Bupivacaine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

13 API Suppliers, 6 USDMF, 1 KDMF, 6 NDC API, 11 Listed Suppliers, $ API Reference Price

13 API Suppliers
6 USDMF
1 KDMF
6 NDC API
11 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

45 Drugs in Development

45 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

108 FDF Dossiers, 9 FDA Orange Book, 79 Europe, 4 South Africa, 16 Listed Dossiers

108 FDF Dossiers
9 FDA Orange Book
79 Europe
4 South Africa
16 Listed Dossiers

RELATED EXCIPIENT COMPANIES

5 DKSH, 2 Nippon Fine Chemical

5 DKSH
2 Nippon Fine Chemical

EXCIPIENTS BY APPLICATIONS

5 Topical, 5 Parenteral, 4 Lubricants & Glidants, 4 Fillers, Diluents & Binders, 1 Co-Processed Excipients, 1 Surfactant & Foaming Agents, 1 Emulsifying Agents, 1 Solubilizers

5 Topical
5 Parenteral
4 Lubricants & Glidants
4 Fillers, Diluents & Binders
1 Co-Processed Excipients
1 Surfactant & Foaming Agents
1 Emulsifying Agents
1 Solubilizers

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 65 News #PharmaBuzz

1 Data Compilation #PharmaFlow
65 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 78 Regulatory FDF Prices

1 US Medicaid Prescriptions
78 Regulatory FDF Prices

MARKET PLACE

6 APIs, 5 FDF Dossiers

6 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

104 US Patents, 6 US Exclusivities

104 US Patents
6 US Exclusivities

REF. STANDARDS & IMPURITIES

2 USP, 3 Others

2 USP
3 Others

$ API Ref.Price (USD/KG) : 904 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Name Reset all filters

6 All

01 4HERON THERAPS INC

02 2PACIRA PHARMS INC

filter Product Reset all filters

6 All

01 2BUPIVACAINE

02 4BUPIVACAINE; MELOXICAM

filter Exclusivity Expiration Date Reset all filters

6 All

01 22026-11-09

02 42027-01-23

filter Exclusivity Code Reset all filters

6 All

01 2I-929

02 4I-933

Product Main Page

PACIRA PHARMS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-929

Exclusivity Expiration Date

2026-11-09

Application Number

22496

Product Number

2

Exclusivity Details

01

PACIRA PHARMS INC

Immuno-Oncology 360

Not Confirmed

PACIRA PHARMS INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE

Exclusivity Code : I-929

Exclusivity Expiration Date : 2026-11-09

Application Number : 22496

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

PACIRA PHARMS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-929

Exclusivity Expiration Date

2026-11-09

Application Number

22496

Product Number

1

Exclusivity Details

02

PACIRA PHARMS INC

Immuno-Oncology 360

Not Confirmed

PACIRA PHARMS INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE

Exclusivity Code : I-929

Exclusivity Expiration Date : 2026-11-09

Application Number : 22496

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

1

Exclusivity Details

03

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

Immuno-Oncology 360

Not Confirmed

HERON THERAPS INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 1

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

4

Exclusivity Details

04

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

Immuno-Oncology 360

Not Confirmed

HERON THERAPS INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 4

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

2

Exclusivity Details

05

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

Immuno-Oncology 360

Not Confirmed

HERON THERAPS INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 2

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

HERON THERAPS INC

Contact Supplier

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

BUPIVACAINE; MELOXICAM

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Exclusivity Code

I-933

Exclusivity Expiration Date

2027-01-23

Application Number

211988

Product Number

3

Exclusivity Details

06

HERON THERAPS INC

BUPIVACAINE; MELOXICAM

Immuno-Oncology 360

Not Confirmed

HERON THERAPS INC

U.S.A

Immuno-Oncology 360

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

BUPIVACAINE; MELOXICAM

Exclusivity Code : I-933

Exclusivity Expiration Date : 2027-01-23

Application Number : 211988

Product Number : 3

Exclusivity Details :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!